Powered by cutting-edge gene editing technologies and a state-of-the-art animal facility, we have developed an integrated platform to support preclinical biologic drug discovery, which includes custom animal and cell model generation, off-the-shelf preclinical animal and cell models, and in vivo/in vitro pharmacology studies.
With facilities in both the US and China, our CRO division (BioMice) has enabled global partnerships with numerous academic and industrial clients to accelerate basic and preclinical research. This brochure provides a brief overview of the following products and services:
